FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Buyback Record Date | |
Buyback Open Date | March 21, 2023 |
Buyback Closing Date | May 12, 2023 |
Issue Size (Amount) | ₹210.00 Crores |
Buyback Price | ₹700 per Share |
June 28, 2024 8:48:00 AM
As of now, we are not able to close anything, but we are hoping in the next couple of years,�� Rajeev Nannapaneni, Director and CEO, Natco Pharma said. On the plans for any buyback plans by ...
Published by : Business LineMay 27, 2024 7:18:00 PM
HYDERABAD: Pharma player Natco Pharma on Monday said it has clocked ... However, for the fiscal year 2023-24, the company clocked its highest ever consolidated net profit at Rs 1388 crore, a ...
Published by : MSNDecember 6, 2023 6:28:00 PM
which gained +2.07% after previously announcing a $1 billion buyback following their share decline, AIA, which fell -0.55%, BYD, which gained +2.6% after announcing a buyback. Having visited BYD ...
Published by : ForbesAugust 9, 2023 1:40:00 PM
Hyderabad based NATCO Pharma Limited has recorded consolidated total revenue of Rs 1160.2 crore for the first quarter ended on 30th June 2023, as against Rs 918.9 crore for the same period last ...
Published by : MSNJune 30, 2024 3:29:00 AM
Natco Pharma Limited is an India-based vertically integrated pharmaceutical company with focus on research and development. The Company is engaged in in the development, manufacturing and ...
Published by : MintAugust 15, 2020 5:59:00 AM
View all information regarding the medicines that are manufactured by Natco Pharma Ltd. including its generic drug name, trade name, how to use, the price, and its composition. Albuterol ...
Published by : MedindiaJuly 16, 2024 3:30:00 AM
Natco Pharma Ltd share price was up by 4.62% from the previous closing price of ?1,259.80. Who are peers of Natco Pharma Ltd? The peers of Natco Pharma Ltd are Sun Pharmaceuticals Industries Ltd ...
Published by : Business TodayJune 24, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarJuly 5, 2024 3:30:00 AM
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Published by : Wall Street JournalJuly 12, 2024 3:30:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Published by : MorningstarRead Natco Pharma Buyback 2023 current news. Find Natco Pharma Buyback 2023 subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Natco Pharma Limited Buyback grey market premium and Natco Pharma Buyback 2023 expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|